Tessera Defense and Homeland Security (HLSQ) vs Liminatus Pharma (LIMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Liminatus Pharma is the larger company by market cap ($4.9 million vs $2.7 million), about 1.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HLSQ | LIMN |
|---|---|---|
| Share price | $0.2953 | $3.67 |
| Market cap | $2.67M | $4.93M |
| 1-day change | +1.30% | -0.54% |
| EPS (TTM) | $-160.60 | $-23.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $122.93 | $141.50 |
| 52-week low | $0.263 | $3.29 |
| Distance from 52-week high | -99.76% | -97.41% |
| Average volume | 640.26K | 453.28K |
| Shares outstanding | 9.03M | 1.34M |
| Employees | 20 | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Tessera Defense and Homeland Security
HLSQ stock →Tessera Defense and Homeland Security Inc. develops and provides defense, homeland security, and critical infrastructure technologies.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 20 employees
About Liminatus Pharma
LIMN stock →Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 1 employees
HLSQ vs LIMN FAQ
Which is bigger, Tessera Defense and Homeland Security or Liminatus Pharma?
Liminatus Pharma (LIMN) is larger, with a market capitalization of $4.93M compared with $2.67M for Tessera Defense and Homeland Security (HLSQ).
Are Tessera Defense and Homeland Security and Liminatus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.